One of those is Boston-based Syntis Bio, which is working on a daily pill that mimics the effects of gastric bypass—no actual ...

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in ...

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Reviews of the latest movies starring Henry Golding and Peter Sarsgaard. Read more at straitstimes.com. Read more at ...

BMO Capital Markets analyst Evan Seigerman said Pfizer’s discontinuation of its GLP-1 pill sends the company back to the starting block as its other obesity drugs are all in the early stages of ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...